Justesen, M.M.; Jakobsen, K.K.; Bendtsen, S.K.; Garset-Zamani, M.; Mordhorst, C.; Carlander, A.-L.F.; Gothelf, A.B.; Grønhøj, C.; von Buchwald, C.
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma. Viruses 2023, 15, 198.
https://doi.org/10.3390/v15010198
AMA Style
Justesen MM, Jakobsen KK, Bendtsen SK, Garset-Zamani M, Mordhorst C, Carlander A-LF, Gothelf AB, Grønhøj C, von Buchwald C.
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma. Viruses. 2023; 15(1):198.
https://doi.org/10.3390/v15010198
Chicago/Turabian Style
Justesen, Marius Meldgaard, Kathrine Kronberg Jakobsen, Simone Kloch Bendtsen, Martin Garset-Zamani, Christine Mordhorst, Amanda-Louise Fenger Carlander, Anita Birgitte Gothelf, Christian Grønhøj, and Christian von Buchwald.
2023. "Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma" Viruses 15, no. 1: 198.
https://doi.org/10.3390/v15010198
APA Style
Justesen, M. M., Jakobsen, K. K., Bendtsen, S. K., Garset-Zamani, M., Mordhorst, C., Carlander, A.-L. F., Gothelf, A. B., Grønhøj, C., & von Buchwald, C.
(2023). Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma. Viruses, 15(1), 198.
https://doi.org/10.3390/v15010198
